Moneycontrol PRO
HomeNewsGmp
Jump to
  • 11 IPOs opening this week: Should you subscribe?

    Between September 22 and 26, as many as 11 mainboard IPOs are opening for public subscription. In this video, we break down every single one of them — dates, price bands, issue sizes, lot details, company background, fund utilisation, and the latest Grey Market Premium (GMP) trends. The 11 IPOs opening this week are: Jain Resource Recycling Seshaasai Technologies Jaro Education Solarworld Energy Solutions Anand Rathi Share & Stock Brokers Ganesh Consumer Products Atlanta Electricals Jinkushal Industries BMW Ventures TruAlt Bioenergy Stay tuned till the end for all the key details and trends you need before deciding whether to subscribe!

  • Prostarm Info Systems IPO subscribed 97x on Day 3, NII portion booked 222x: Check the latest GMP

    Prostarm IPO GMP: The inverter-maker's IPO entirely comprises a fresh issue of 1.6 crore equity shares at a price band of Rs 95-105 per share

  • Laxmi Dental IPO subscribed 16x on Day 2, NIIs lead with 37x bidding

    Retail investors have booked their reserved portion 29.47 times. The portion reserved for Qualified Institutional Buyers (QIBs) is yet to be fully booked and has been subscribed 84%.

  • Laxmi Dental IPO sees 5x subscription on Day 1, retail portion booked 12x

    Laxmi Dental IPO Day 1: The portion reserved for non-institutional investors was subscribed 10.85 times.

  • 186x subscription in 3 days! Quadrant Future Tek’s Rs 290-crore IPO closes, NII portion booked 254x

    Ahead of the listing, Quadrant Future Tek’s unlisted shares were trading with a GMP of around 72.41% at Rs 500 per share

  • Grey market premiums point towards strong listing for upcoming IPOs

    Orient Technologies, which is set to list on August 28, has a grey market premium (GMP) of Rs 82 against its price band of Rs 195-206 per share. Premier Energies, which plans to list on September 3, shows a GMP of Rs 330 against its price band of Rs 427-450 per share.

  • Surge in grey market premium shows rising interest in public issues

    Recently listed Mankind Pharma surged over 30 percent on listing day from its price band while Ikio Lighting Ltd shares debuted over 56 percent premium from its issue price

  • Biocon Biologics' new manufacturing plant in Bengaluru gets EU certification

    The manufacturing facility will enhance the company's capability to manufacture drug substance of monoclonal antibodies portfolio.

  • LIC IPO: Rate hike causes grey market premium to plummet by 30%

    Market watchers expect it to recover in a day or two

  • Tega Industries, MapmyIndia trading at premium in grey market, here's how other IPOs are doing

    In yet another busy week for the primary market, Star Health is trading at a discount in the grey market ahead of its listing but Tega Industries, Anand Rathi, RateGain Travel, and others are trading at a premium

  • COVID-19 vaccine update | Covaxin receives GMP certificate from Hungary, says Bharat Biotech

    The approval was received from the National Institute of Pharmacy and Nutrition, Hungary certifying the GMP for the manufacture of Covaxin.

  • Startup Get My Parking launches on street smart parking

    With 50,000 parking spots in Delhi and appreciation by honorable PM Narendra Modi for their work in Kumbh Mela, they are now market leaders in mobile-based smart parking technology.

  • Shilpa Medicare up 15% on GMP certificate from Japan regulator

    "Shilpa received GMP compliance certificate for two active pharmaceutical ingredient (API) sites from Pharmaceuticals and Medical Devices Agency, Japan," the Karnataka based pharma company said.

  • Wockhardt gains, Chikalthana unit gets UK MHRA certificate

    "The company has undergone recently an inspection at its L1-Chikalthana, Aurangabad manufacturing facility by UK MHRA and have received a communication confirming the closure of the inspection and issuance of an unrestricted GMP certificate," the pharma company said in its filing.

  • Caplin Point up 5% on EU GMP nod for unit in Chennai

    The company says that the site was inspected by EU authorities in March and has been certified as compliant with the guidelines. "The facility is capable of manufacturing liquid injectables in Vials, Ampoules, Lyophilized Vials and Opthalmic dosages," it says in a statement to the exchanges.

  • Exports contribution to revenue may rise to 40%: Aarti

    Adhish Patil, CFO, Aarti Drugs, says the contribution of exports to revenue is likely to increase to 40 percent. The company got WHO good manufacturing practice (GMP) for the anti-diabetic drug in the first week of June.

  • Wockhardt up 5%, USFDA gives clean chit to Chikalthana unit

    Shares of Wockhardt rallied 5.4 percent intraday Thursday after the US health regulator has not found any issues at Chikalthana plant.

  • Sharon Bio up 10%, gets GMP certificate Uttarakhand unit

    Investors queued up for buying shares of Sharon Bio Medicine on Wednesday after the pharma company received good manufacturing practices certificate for its Uttarakhand unit. The stock is locked at 10 percent upper circuit.

  • Jubilant Foodworks bags IBLA

    What do an IT services company, a gas company, a pizza & donut shop, a financial services company and india's largest gold loan company have in common? They all passed rigourous quantitative performance tests to qualify as nominations for most promising company of the year award at CNBC TV18's India Business Leader Awards (IBLA).

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347